MEmbrane estrogen receptors - Is it an alternative way of estrogen action?

Journal of Physiology and Pharmacology

Volumn 64, Issue 2, 2013, Pages

  Soltysik, K ^a   Czekaj, P ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

ER X; ERx; Estrogens; GPER; Membrane estrogen receptor; Nuclear estrogen receptor; Signal transduction; Signalosome

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CELL NUCLEUS RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FAK PROTEIN; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; GEFITINIB; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MOESIN; PELP1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE P60; PROTEIN SHC; RAS PROTEIN; REGULATOR PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BREAST CANCER; CARCINOGENESIS; HORMONE ACTION; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 84878908940     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Kumar R, Zakharov MN, Khan SH, et al. The dynamic structure of the estrogen receptor. J Amino Acids 2011; 2011: 812540.
2. Jacob J, Sebastian KS, Devassy S, et al. Membrane estrogen receptors: genomic actions and post transcriptional regulation. Mol Cell Endocrinol 2006; 246: 34-41.
3. Lachowicz-Ochedalska A. Membrane receptors for estradiol-new way of biological action. Endokrynol Pol 2005; 56: 322-326.
4. Moriarty K, Kim KH, Bender JR. Estrogen receptor-mediated rapid signaling. Endocrinology 2006; 147: 5557-5563.
5. Gunn BG, Brown AR, Lambert JJ, Belelli D. Neurosteroids and GABA(A) receptor interactions: a focus on stress. Front Neurosci 2011; 5: 131.
6. Szego CM, Davis JS. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 1967; 58: 1711-1718.
7. Bulayeva NN, Wozniak AL, Lash LL, Watson CS. Mechanisms of membrane estrogen receptor-a-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am J Physiol Endocrinol Metab 2005; 288: E388-E397.
8. Norfleet AM, Clarke CH, Gametchu B, Watson CS. Antibodies to the estrogen receptor-a modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J 2000; 14: 157-165.
9. Watson CS, Campbell CH, Gamethu B. Membrane oestrogen receptors on rat pituitary tumour cells: immuno-identification and responses to oestradiol and xenoestrogens. Exp Physiol 1999; 84: 1013-1022.
10. Benten WP, Stephan C, Lieberherr M, Wunderlich F. Estradiol signaling via sequestrable surface receptors. Endocrinology 2001; 142: 1669-1677.
11. Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006; 20: 1996-2009.
12. Stefano GB, Prevot V, Beauvillain JC, et al. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: evidence for an estrogen surface receptor. J Immunol 1999; 163: 3758-3763.
13. Wu TW, Chen S, Brinton RD. Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons. Brain Res 2011; 1379: 34-43.
14. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER. Identification of a structural determinant necessary for the localization and function of estrogen receptor a at the plasma membrane. Mol Cell Biol 2003; 23: 1633-1646.
15. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER(alpha) and ER(beta) expressed in chinese hamster ovary cells. Mol Endocrinol 1999; 13: 307-319.
16. Zivadinovic D, Gametchu B, Watson CS. Membrane estrogen receptor-levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 2005; 7: R101-R112.
17. Prevot V, Croix D, Rialas CM, et al. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology 1999; 140: 652-659.
18. Ropero AB, Soria B, Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 2002; 16: 497-505.
19. Pedram A, Razandi M, Aitkenhead M, Levin ER. Estrogen inhibits cardiomyocyte hypertrophy in vitro. J Biol Chem 2005; 280: 26339-26348.
20. Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol Endocrinol 2005; 19: 1606-1617.
21. Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 2000; 14: 1434-1447.
22. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER. Integration of the non-genomic and genomic actions of estrogen. J Biol Chem 2002; 277: 50768-50775.
23. Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, Silva CM. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 2008; 22: 1781-1796.
24. Ho KJ, Liao JK. Nonnuclear actions of estrogen. Arterioscler Thromb Vasc Biol 2002; 22: 1952-1961.
25. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER. Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 2004; 18: 2854-2865.
26. Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 1995; 9: 404-410.
27. Levin ER. Membrane oestrogen receptor a signalling to cell functions. J Physiol 2009; 587: 5019-5023.
28. Nadal A, Ropero AB, Fuentes E, Soria B. The plasma membrane estrogen receptor: nuclear or unclear? Trends Pharmacol Sci 2001; 22: 597-599.
29. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERb has nongenomic action in caveolae. Mol Endocrinol 2002; 16: 938-946.
30. Pedram A, Razandi M, Deschenes RJ, Levin ER. DHHC-7 and-21 are palmitoylacyltransferases for sex steroid receptors. Mol Biol Cell 2012; 23: 188-199.
31. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007; 282: 22278-22288.
32. Razandi M, Pedram A, Levin ER. Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 2010; 30: 3249-3261.
33. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL. An estrogen receptor (ER) deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 2002; 16: 2188-2201.
34. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009; 20: 477-482.
35. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. Caveolin-1 potentiates estrogen receptor a (ERa) signaling. J Biol Chem 1999; 274: 33551-33556.
36. Li L, Haynes MP, Bender JR. Plasma membrane localization and function of the estrogen receptor a variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 2003; 100: 4807-4812.
37. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004; 101: 17126-17131.
38. Taguchi Y, Koslowski M, Bodenner DL. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl Recept 2004; 2: 5.
39. Mermelstein PG, Micevych PE. Nervous system physiology regulated by membrane estrogen receptor. Rev Neurosci 2008; 19: 413-424.
40. Micevych P, Dominguez R. Membrane estradiol signaling in the brain. Front Neuroendocrinol 2009; 30: 315-327.
41. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE. Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 1999; 140: 5455-5458.
42. Arreguin-Arevalo JA, Nett TM. A nongenomic action of 17ß-estradiol as the mechanism underlying the acute suppression of secretion of luteinizing hormone. Biol Reprod 2005; 73: 115-122.
43. Moats II RK, Ramirez VD. Electron microscopic visualization of membrane-mediated uptake and translocation of estrogen-BSA: colloidal gold by Hep G2 cells. J Endocrinol 2000; 166: 631-647.
44. Guo X, Razandi M, Pedram A, Kassab G, Levin ER. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 2005; 280: 19704-19710.
45. Song RX, Santen RJ. Membrane initiated estrogen signaling in breast cancer. Biol Reprod 2006; 75: 9-16.
46. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 2004; 101: 2076-2081.
47. Pietras RJ, Marquez-Garban DC. Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res 2007; 13: 4672-4676.
48. Li L, Hisamoto K, Kim KH, et al. Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci USA 2007; 104: 16468-16473.
49. Simoncini T, Rabkin E, Liao JK. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 198-203.
50. Kim KH, Bender JR. Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol 2009; 308: 3-8.
51. Luoma JI, Boulware MI, Mermelstein PG. Caveolin proteins and estrogen signaling in the brain. Mol Cell Endocrinol 2008; 290: 8-13.
52. Helguero LA, Lindberg K, Gardmo C, Schwend T, Gustafsson JA, Haldosen LA. Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line. Cancer Res 2008; 68: 8695-8704.
53. Pedram A, Razandi M, Kim JK, et al. Developmental phenotype of a membrane only estrogen receptor a (MOER) mouse. J Biol Chem 2009; 284: 3488-3495.
54. Schendzielorz N, Rysa A, Reenila I, Raasmaja A, Mannisto PT. Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats. J Physiol Pharmacol 2011; 62: 483-490.
55. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005; 19: 833-842.
56. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 1997; 138: 4030-4033.
57. Vasudevan N, Pfaff DW. Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 2007; 28: 1-19.
58. Vasudevan N, Kow LM, Pfaff DW. Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc Natl Acad Sci USA 2001; 98: 12267-12271.
59. Syed FA, Modder UI, Fraser DG, et al. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J Bone Miner Res 2005; 20: 1992-2001.
60. Almeida M, Martin-Millan M, Ambrogini E, et al. Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERa. J Bone Miner Res 2010; 25: 769-781.
61. Syed FA, Fraser DG, Monroe DG, Khosla S. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone 2011; 49: 208-216.
62. Watson CS, Alyea RA, Jeng YJ, Kochukov MY. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 2007; 274: 1-7.
63. Haynes MP, Sinha D, Russell KS, et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000; 87: 677-682.
64. Townsend EA, Thompson MA, Pabelick CM, Prakash YS. Rapid effects of estrogen on intracellular Ca2+ regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2010; 298: L521-L530.
65. Micevych P, Christensen A. Membrane-initiated estradiol actions mediate structural plasticity and reproduction. Front Neuroendocrinol 2012; 33: 331-341.
66. Pedram A, Razandi M, Evinger AJ, Lee E, Levin ER. Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell 2009; 20: 3374-3389.
67. Lim KT, Cosgrave N, Hill AD, Young LS. Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1. Breast Cancer Res 2006; 8: R33.
68. Mintz PJ, Habib NA, Jones JL, et al. The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer. Cancer 2008; 113: 1489-1495.
69. Razandi M, Pedram A, Rosen EM, Levin ER. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 2004; 24: 5900-5913.
70. Giretti MS, Fu XD, De Rosa G, et al. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS One 2008; 3: e2238.
71. Chakravarty D, Nair SS, Santhamma B, et al. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Cancer Res 2010; 70: 4092-4101.
72. Li Y, Wang JP, Santen RJ, et al. Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology 2010; 151: 5146-5156.
73. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T. Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 2010; 24: 2114-2125.
74. Kauss MA, Reiterer G, Bunaciu RP, Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid induced cell differentiation. Exp Cell Res 2008; 314: 2999-3006.
75. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625-1630.
76. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146: 624-632.
77. Otto C, Rohde-Schulz B, Schwarz G, et al. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 2008; 149: 4846-4856.
78. Filardo E, Quinn J, Pang Y, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007; 148: 3236-3245.
79. Madeo A, Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 2010; 70: 6036-6046.
80. Hazell GG, Yao ST, Roper JA, Prossnitz ER, O'Carroll AM, Lolait SJ. Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J Endocrinol 2009; 202: 223-236.
81. Chevalier N, Vega A, Bouskine, et al. A GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 2012; 7: e34672.
82. Rettew JA, McCall SH, Marriott I. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol Cell Endocrinol 2010; 328: 87-92.
83. Blasko E, Haskell CA, Leung S, et al. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 2009; 214: 67-77.
84. Gingerich S, Kim GL, Chalmers JA et al. Estrogen receptor a and G-protein coupled receptor 30 mediate the neuroprotective effects of 17ß-estradiol in novel murine hippocampal cell models. Neuroscience 2010; 170: 54-66.
85. Chimento A, Sirianni R, Delalande C, et al. 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha. Mol Cell Endocrinol 2010; 320: 136-144.
86. Filice E, Recchia AG, Pellegrino D, Angelone T, Maggiolini M, Cerra MC. A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. J Physiol Pharmacol 2009; 60: 3-10.
87. Gros R, Ding Q, Sklar LA, et al. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011; 57: 442-451.
88. Otto C, Fuchs I, Kauselmann G, et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 2009; 80: 34-41.
89. Kolkova Z, Casslen V, Henic E. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer. J Ovarian Res 2012; 5: 9.
90. Albanito L, Madeo A, Lappano R, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67: 1859-1866.
91. Ariazi EA, Brailoiu E, Yerrum S, et al. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 2010; 70: 1184-1194.
92. Vivacqua A, Bonofiglio D, Recchia AG, et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006; 20: 631-646.
93. Vigen RA, Chen D, Syversen U, Stunes K, Hakanson R, Zhao CM. Serum gastrin and gastric enterochromaffin-like cells during estrous cycle, pregnancy and lactation, and in response to estrogen-like agents in rats. J Physiol Pharmacol 2011; 62: 335-340.
94. Kim SM, Jung EM, An BS, et al. Additional effects of bisphenol A and paraben on the induction of calbindin-D(9K) and progesterone receptor via an estrogen receptor pathway in rat pituitary GH3 cells. J Physiol Pharmacol 2012; 63: 445-455.
95. Albanito L, Lappano R, Madeo A, et al. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008; 116: 1648-1655.
96. Du GQ, Zhou L, Chen XY, Wan XP, He YY. The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells Biochem Biophys Res Commun 2012; 420: 343-349.
97. Ignatov A, Ignatov T, Roessner A, Costa SD, Kalinski T. Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res Treat 2010; 123: 87-96.
98. Kuo J, Hamid N, Bondar G, Prossnitz ER, Micevych P. Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J Neurosci 2010; 30: 12950-12957.
99. Dennis MK, Burai R, Ramesh C, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol 2009; 5: 421-427.
100. Isensee J, Meoli L, Zazzu V, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 2009; 150: 1722-1730.
101. Martensson UE, Salehi SA, Windahl S, et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 2009; 150: 687-698.
102. Windahl SH, Andersson N, Chagin AS, et al. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol Endocrinol Metab 2009; 296: E490-E496.
103. Haas E, Bhattacharya I, Brailoiu E, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009; 104: 288-291.
104. Ford J, Hajibeigi A, Long M, et al. GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. J Bone Miner Res 2011; 26: 298-307.
105. Wang C, Dehghani B, Magrisso IJ, et al. GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol 2008; 22: 636-648.
106. Langer G, Bader B, Meoli L, et al. A critical review of fundamental controversies in the field of GPR30 research. Steroids 2010; 75: 603-610.
107. Delbeck M, Golz S, Vonk R, et al. Impaired left-ventricular cardiac function in male GPR30-deficient mice. Mol Med Rep 2011; 4: 37-40.
108. Toran-Allerand CD, Guan X, MacLusky NJ. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 2002; 22: 8391-401.
109. Kampa M, Notas G, Pelekanou V, et al. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: first pharmacological evidence for a novel membrane estrogen receptor element (ERx). Steroids 2012; 77: 959-967.
110. Kang L, Zhang X, Xie Y, et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 2010; 24: 709-721.
111. Zhang X, Ding L, Kang L, Wang ZY. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells. PLoS One 2012; 7: e30174.